Indeed, several studies have supported the notion that deglycosylation of tumour tissues improves predictive ability of PD‐L1 expression in tumours as a marker for anti‐PD‐1/PD‐L1 therapy.10, 11, 12. Here, CD274 is linked to neoplasm.